ABC | Volume 114, Nº2, Fevereiro 2020

Minieditorial Chamié e Abizaid Avaliação fisiológica invasiva: do binário ao contínuo Arq Bras Cardiol. 2020; 114(2):265-267 Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons 5. Grondin CM, Dyrda I, Pasternac A, Campeau L, Bourassa MG, Lespérance J. Discrepancies between cineangiographic and postmortem findings in patients with coronary artery disease and recent myocardial revascularization. Circulation . 1974;49(4):703–8. 6. Brueren BRG, Ten Berg JM, Suttorp MJ, Bal ET, Ernst JMPG, Mast EG, et al. How good are experienced cardiologists at predicting the hemodynamic severity of coronary stenoses when taking fractional flow reserve as the gold standard. Int J Cardiovasc Imaging . 2002;18(2):73–6. 7. Tonino PAL, FearonWF, De Bruyne B, Oldroyd KG, Leesar MA, Ver Lee PN, et al. Angiographic Versus Functional Severity of Coronary Artery Stenoses in the FAME Study. Fractional FlowReserve Versus Angiography inMultivessel Evaluation. J Am Coll Cardiol . 2010;55(25):2816–21. 8. BodenWE, O’Rourke RA, Teo KK, Hartigan PM, MaronDJ, KostukWJ, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med . 2007;356(15):1503–16. 9. HachamovitchR,BermanDS,ShawLJ,KiatH,Cohen I,ArthurCabico J,etal. Incrementalprognosticvalueofmyocardialperfusionsinglephotonemission computed tomography for the prediction of cardiac death: Differential stratification for risk of cardiac death andmyocardial infarction. Circulation . 1998;97(6):535–43. 10. Zimmermann FM, Ferrara A, Johnson NP, Van Nunen LX, Escaned J, Albertsson P, et al. Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial. Eur Heart J . 2015;36(45):3182–8. 11. Tonino PAL, De Bruyne B, Pijls NHJ, Siebert U, Ikeno F, Van’t Veer M, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med . 2009;360(3):213–24. 12. Sen S, Escaned J, Malik IS, Mikhail GW, Foale RA, Mila R, et al. Development and validation of a new adenosine-independent index of stenosis severity from coronary waveintensity analysis: Results of the ADVISE (ADenosine Vasodilator Independent Stenosis Evaluation) study. J Am Coll Cardiol . 2012;59(15):1392–402. 13. Davies JE, Sen S, Dehbi H-M, Al-Lamee R, Petraco R, Nijjer SS, et al. Use of the InstantaneousWave-free Ratio or Fractional FlowReserve in PCI. N Engl J Med . 2017;376(19):1824–34. 14. Götberg M, Christiansen EH, Gudmundsdottir IJI, Sandhall L, Danielewicz M, Jakobsen L, et al. Instantaneous Wave-free Ratio versus Fractional Flow Reserve to Guide PCI. N Engl J Med . 2017;376(19):1813–23. 15. Jeremias A, Maehara A, Généreux P, Asrress KN, Berry C, De Bruyne B, Davies JE, Escaned J, FearonWF, Gould KL, Johnson NP, Kirtane AJ, Koo BK, Marques KM, Nijjer S, Oldroyd KG, Petraco R, Piek JJ, Pijls NH, Redwood S, Siebes M, Spaan JAE, Van’T Veer M, Mintz GS, Stone GW. Multicenter core laboratory comparison of the instantaneous wave-free ratio and resting Pd/Pawith fractional flow reserve: The RESOLVE study. J Am Coll Cardiol . 2014;63(13):1253–61. 16. VieiraHCA,FerreiraMCM,NunesLC,CardosoCJF,NascimentoEM,Oliveira GMM. Avaliação de Isquemia Miocárdica na Sala de Hemodinâmica com iFR Instantaneous Wave-Free Ratio: Estudo Piloto. Arq Bras Cardiol. 2020; 114(2):256-264. 17. Weintraub WS, Spertus JA, Kolm P, Maron DJ, Zhang Z, Jurkovitz C, et al. Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med . 2008;359(7):677–87. 18. Al-Lamee R, Howard JP, Shun-Shin MJ, Thompson D, Dehbi HM, Sen S, et al. Fractional flow reserve and instantaneous wave-free ratio as predictors of the placebo-controlled response to percutaneous coronary intervention in stable single-vessel coronary artery disease: Physiology-stratified analysis of ORBITA. Circulation . 2018;138(17):1780–92. 19. AhmadiA,NarulaJ.PrecludingRevascularization inStableCoronaryDisease: The Power of Double Negatives. J Am Coll Cardiol . 2018;72(16):1936–9. 20. Xaplanteris P, Fournier S, Pijls NHJ, FearonWF, Barbato E, Tonino PAL, et al. Five-year outcomes with PCI guided by fractional flow reserve. N Engl J Med . 2018;379:250–259. 21. HachamovitchR,HayesSW,FriedmanJD,Cohen I,BermanDS.Comparison oftheshort-termsurvivalbenefitassociatedwithrevascularizationcompared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation . 2003;107(23):2900–7. 22. Ahn JM, Park DW, Shin ES, Koo BK, Nam CW, Doh JH, et al. Fractional Flow Reserve and Cardiac Events in Coronary Artery Disease: Data from a Prospective IRIS-FFR Registry (Interventional Cardiology Research Incooperation Society Fractional Flow Reserve). Circulation . 2017;135(23)2241–51. 23. JohnsonNP,TóthGG,LaiD,ZhuH,AçarG,AgostoniP,etal.Prognosticvalue of fractional flow reserve: Linking physiologic severity to clinical outcomes. J Am Coll Cardiol . 2014;64(16):1641–54. 24. Jeremias A, Davies JE, Maehara A, Matsumura M, Schneider J, Tang K,et al. Blinded Physiological Assessment of Residual Ischemia After Successful Angiographic Percutaneous Coronary Intervention: The DEFINE PCI Study. JACC Cardiovasc Interv . 2019;12(20):1991–2001. 25. Gould KL, Lipscomb K. Effects of coronary stenoses on coronary flow reserve and resistance. Am J Cardiol . 1974;34(1):48–55. 26. Nijjer SS, Dewaard GA, Sen S, Van De Hoef TP, Petraco R, Echavarría- Pinto M, et al. Coronary pressure and flow relationships in humans: Phasic analysis of normal and pathological vessels and the implications for stenosis assessment: A report from the Iberian-Dutch-English (IDEAL) collaborators. Eur Heart J . 2016;37(26):2069–80. 267